FGFR1 and cancer: Helsten et al.3 reported that of the 7.1% of FGFR1–4-altered cancers in their cohort of 4853 tumours, 66% of the aberrations were due to CNAs, while 26% were SNVs, and 8% were gene rearrangements or fusions.